Quince Therapeutics Financial Overview
Quince Therapeutics's market cap is currently $198.78M. The company's EPS TTM is $-0.25; its P/E ratio is -2.99; Quince Therapeutics is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-0.18. See an overview of income statement, balance sheet, and cash flow financials.
